(PharmaNewsWire.Com, January 21, 2017 ) DelveInsight Report, "Chimeric Antigen Receptor (CAR) T cell Immunotherapy- Competitive Landscape, Technology and Pipeline Analysis, 2016" emphasizes on the currently active CAR-T cell products in research and development. The Report covers the 40+ companies which are active in this field including 27 leading companies with 101 products targeting 44 different antigens and 24 different technologies. The Report provides in-depth analysis on the CAR-T cell profiles covering pre-clinical and clinical studies, Collaborations details and Deal values, Technologies and Targeted antigens. The Report provides the CAR-T licensing opportunities, acquisitions, market drivers and barriers followed by SWOT Analysis. Report also describes the unmet needs covered by CAR-T cells highlighting the adverse events, which are major concerns in the market for the usage of CAR-T cells.
- Pipeline intelligence and complete understanding over therapeutics development of CAR-T cell products to exploit opportunities - Explore outcomes of Pre-clinical and clinical studies and Identify prominent therapeutic areas - Develop & design strategies to gain competitive advantage by tracking the latest CAR-T technologies and associated innovative companies - Track in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Uncovering opportunities in the rapidly growing market, Optimize portfolio, keep updated and make the best decisions for business development - Identifying the upcoming leaders and products in the CAR-T cell therapy market in the coming years - Understand the CAR-T competitive landscape, plan mergers and acquisitions effectively by identifying key players of the most promising
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: